{"text_format":"2","workbook":"xlsx","n_sheets":2,"sheets":["工作表1","工作表2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":0,"defined_names":0,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"工作表1","index":0,"n_rows":12,"n_cols":20,"rows_kept":12,"cut":false,"hidden":false,"merged":[]}
["流水號","gender","收案時年齡 (yr)","診斷","診斷年月","收案年月","抽菸史","自體免疫甲狀腺疾病家族史","身高 (cm)","體重 (kg)","收集檢體當時的FT4 (ng/dl)","收集檢體當時的TSH (mIU/L)","收集檢體當時的T3(pg/ml)","收集檢體當時的 anti-Tg (IU/ml)","收集檢體當時的 anti-TPO (IU/ml)","收集檢體當時的  TSHR Ab     (IU/L) 或(%)","Hyperthyroidism病人收案時是否已用藥","hyperthyroidism 收案時 使用methimmazole 或PTU劑量 (mg/day)","Hypothyroidism 收案時使用levothyroxin劑量(mg/day)","Hyperthyroidism病人 用藥後是否有達到疾病緩解和停藥"]
[{"$nulls":11}," "]
[]
[]
[]
[]
[]
[]
["Note:"]
["anti-Tg: anti-thyroglobulin antibody"]
["anti-TPO: anti-thyroid peroxidase antibody "]
["TSHRAb: thyroid-stimulating hormone receptor antibody "]

{"sheet":"工作表2","index":1,"n_rows":4,"n_cols":4,"rows_kept":4,"cut":false,"hidden":true,"merged":[]}
["抽菸史","自體免疫甲狀腺疾病家族史","Hyperthyroidism病人收案時是否已用藥","Hyperthyroidism病人 用藥後是否有達到疾病緩解和停藥"]
["0.無抽菸;","0. 無","0. 無","0. 無"]
["1.過去有抽菸, 但已戒菸","1. 有","1. 有","1. 有"]
["2. 有, 每天幾支"]